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Abstract
Background: Genome and transcriptome studies of Plasmodium nucleic acids obtained from parasitized whole
blood are greatly improved by depletion of human DNA or enrichment of parasite DNA prior to next-generation
sequencing and microarray hybridization. The most effective method currently used is a two-step procedure to
deplete leukocytes: centrifugation using density gradient media followed by filtration through expensive,
commercially available columns. This method is not easily implemented in field studies that collect hundreds of
samples and simultaneously process samples for multiple laboratory analyses. Inexpensive syringes, hand-packed
with CF11 cellulose powder, were recently shown to improve ex vivo cultivation of Plasmodium vivax obtained
from parasitized whole blood. This study was undertaken to determine whether CF11 columns could be adapted
to isolate Plasmodium falciparum DNA from parasitized whole blood and achieve current quantity and purity
requirements for Illumina sequencing.
Methods: The CF11 procedure was compared with the current two-step standard of leukocyte depletion using
parasitized red blood cells cultured in vitro and parasitized blood obtained ex vivo from Cambodian patients with
malaria. Procedural variations in centrifugation and column size were tested, along with a range of blood volumes
and parasite densities.
Results: CF11 filtration reliably produces 500 nanograms of DNA with less than 50% human DNA contamination,
which is comparable to that obtained by the two-step method and falls within the current quality control
requirements for Illumina sequencing. In addition, a centrifuge-free version of the CF11 filtration method to isolate
P. falciparum DNA at remote and minimally equipped field sites in malaria-endemic areas was validated.
Conclusions: CF11 filtration is a cost-effective, scalable, one-step approach to remove human DNA from
P. falciparum-infected whole blood samples.
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Background
Recent technological advances have enabled next-gen-
eration genomic and transcriptomic analysis of Plasmo-
dium falciparum from parasitized whole blood samples
without the need for culturing. High-density genotyping
of parasites obtained directly from patients with malaria
has improved our understanding of population structure
and genomic and transcriptional variation [1,2]. Highly
parallel sequencing is currently being used to identify
the genetic determinants of clinically relevant pheno-
types including drug resistance, vaccine escape and dis-
ease severity. Importantly, genomic characterization of
parasite populations in patients captures intra-host
diversity and prevents the potential loss of sequence
data from phenotype-conferring parasite isolates during
their culture adaptation.
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The performance of highly parallel sequencing plat-
forms, such as Illumina, is greatly enhanced in sample
preparations with a high parasite-to-human nucleic acid
ratio [3]. Such high ratios can be achieved by either
selectively capturing parasite nucleic acids or by remov-
ing human material from the sample. Hybrid selection
[4] using RNA ‘baits’ complementary to the P. falci-
parum genome can achieve over 40-fold enrichment of
parasite DNA and can be performed at any time follow-
ing DNA extraction [5]; however, at $250 USD per sam-
ple, this technique may be prohibitively costly for
epidemiological or population-level studies.
The alternative, leukocyte depletion, must be per-
formed in field sites soon after blood collection and
before transport and storage. Commercially available
magnetic columns have been used to rapidly isolate
parasitized red blood cells (RBCs) from uninfected RBCs
and leukocytes [6]. However, magnetic purification
depends on short-term culturing of patient blood to
transform ring-stage parasites to haemozoin-rich tro-
phozoites and schizonts, which requires equipment for
in vitro parasite cultivation. Furthermore, parasites
obtained directly from patients mature at different rates
in culture, resulting in inconvenient time-points for pur-
ification. The current standard for leukocyte depletion
of parasitized blood for P. falciparum nucleotide
sequencing is a two-step process: centrifugation using
Lymphoprep or another sucrose density gradient solu-
tion, followed by filtration using Plasmodipur filters [3].
This ‘LP’ method is effective but difficult to scale-up in
field settings because it requires extensive handling and
transfer of blood, training to perform sensitive steps,
and costly commercial reagents and materials.
Filtration with hand-made columns has been used as
an inexpensive and less time-consuming alternative for
leukocyte depletion of Plasmodium-infected blood for
decades [7,8]. Recently, non-woven fabric filters [9] and
plastic syringes filled with CF11 cellulose powder
(Whatman) [10] were shown to effectively remove leu-
kocytes and platelets from Plasmodium vivax-infected
blood, where their phagocytic and degranulating activ-
ities may interfere with some ex vivo studies. CF11 fil-
tration has also been used to improve microarray-based
transcriptome analysis of P. vivax-infected blood [2,11].
CF11 cellulose is thought to work by trapping leuko-
cytes by size exclusion and/or interactions between cel-
lulose hydroxyl groups and leukocyte surface molecules.
In this study, laboratory-adapted P. falciparum clones
were used to adapt CF11 columns to remove human
DNA from P. falciparum-infected blood for genomic
studies, compare CF11 filtration to the established LP
method, and validate a centrifuge-free option for CF11
filtration. Both methods were also compared in a field
setting using P. falciparum isolates obtained directly
from patients with malaria. Furthermore, routine CF11
filtration of parasitized blood collected from patients in
a second field site with minimal facilities was success-
fully implemented.
Methods
Blood samples
Experiments using laboratory-adapted P. falciparum
clones were conducted at the University of Maryland,
Baltimore. Blood obtained from healthy volunteers was
mixed with purified P. falciparum parasites (3D7 or Dd2
clones) to achieve parasite densities of 10,000/μl and
5,000/μl. These samples were stored at 4°C for up to
two hours prior to CF11 or LP filtration.
Experiments using non-adapted P. falciparum isolates
were conducted in August 2010 at Sampov Meas Refer-
ral Hospital, Pursat, Cambodia. Blood samples for these
experiments were collected from patients with falci-
parum malaria who were ≥ 10 years old and had a wide
range of parasite densities (≥ 10,000/μl). These samples
were held at 4°C for up to six hours prior to CF11 or
LP filtration. Additional blood samples were collected in
November to December 2010 at Lumphat District
Health Centre, Ratanakiri, Cambodia. Blood samples
were obtained from patients with falciparum malaria
who were ≥ 1 year old and had a wide range of parasite
densities ≥ 10,000/μl. These samples were held at 4°C
for up to six hours prior to CF11 filtration. Following
CF11 filtration, samples were stored on ice for up to six
hours and transported on ice for up to 12 hours to
Phnom Penh for centrifugation and RBC pellet storage.
All blood samples were collected in EDTA or CPDA-1
tubes. Heparin was not used as an anticoagulant as it
thought to inhibit Taq polymerase during DNA
amplification.
Blood samples from healthy volunteers were collected
under a protocol approved by the Institutional Review
Board of the University of Maryland School of Medicine.
Blood samples from patients with falciparum malaria
were collected under protocols approved by the Institu-
tional Review Board of the National Institute for Allergy
and Infectious Diseases and the Cambodian National
Ethics Committee for Health Research (http://Clinical-
Trials.gov identifiers: NCT00341003 and NCT01240603).
Written, informed consent was obtained from all study
participants or their parents or guardians.
Leukocyte depletion
Lymphoprep (Axis-shield, Oslo, Norway) + Plasmodipur
(Euro-diagnostica, Arnhem, Netherlands) filtration (’LP’)
was performed as previously described [3]. CF11 col-
umns were loosely filled to the 10-ml mark, packed to
the 5.5-ml mark with CF11 cellulose powder (Whatman,
Kent, UK), and wetted with isotonic phosphate buffered
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saline (PBS), as described [10]. Initial tests indicated that
plasma separation prior to CF11 filtration of blood did
not affect human DNA depletion and that washing with
PBS after CF11 filtration improved recovery of parasite
DNA. CF11 filtration was therefore carried out as fol-
lows. Parasitized blood or blood/parasite mixtures were
diluted with an equal volume of PBS. These samples
were added to the CF11 column and allowed to flow
through by gravity. To wash the sample, 5 ml PBS was
added to the column and allowed to pass through by
gravity. A plunger was then inserted into the top of the
column and the final few drops pushed through the col-
umn. The filtrates were centrifuged for 10 minutes at
1,000 x g and the supernatants removed. RBC pellets
from all filtrates in all experiments were stored at -20°C
until DNA extraction. A packed CF11 column and filtra-
tion of blood diluted with PBS are shown in Figures 1A
and 1B. The full CF11 filtration procedure is available
on the WWARN website [12].
Experimental design
CF11 versus LP filtration, without modifications
To compare the CF11 and LP methods for leukocyte
depletion in a laboratory setting, three replicates of
blood-parasite mixtures (3-ml volume; 10,000 parasites/
μl) were prepared and filtered in parallel using each
method
Experimental design
CF11 versus LP filtration, without modifications
To compare the CF11 and LP methods for leukocyte
depletion in a laboratory setting, three replicates of
blood-parasite mixtures (3-ml volume; 10,000 parasites/
μl) were prepared and filtered in parallel using each
method. Unfiltered blood-parasite mixtures were pre-
pared as control samples. To compare the two methods
in a field setting (Pursat, Cambodia), 8 ml blood from
15 patients with falciparum malaria were obtained and
split into two 4-ml aliquots. Each aliquot was processed
by either the CF11 or LP method.
CF11 filtration, with procedural modifications
To test a centrifuge-free method of CF11 filtration,
three replicates of blood-parasite mixtures (3-ml
volume; 10,000 parasites/μl) were prepared, filtered
through CF11 columns, and held overnight at 4°C to
allow RBCs pellet by gravity. Supernatants were
removed the following day. To investigate the effect of
decreased CF11 column length on leukocyte depletion,
three replicates of blood-parasite mixtures (3-ml
volume; 10,000 parasites/μl) were filtered through col-
umns loosely filled with CF11 to the 8-ml mark and
packed to the 4-ml mark.
Modifications in blood volume and parasite density
To investigate the effect of low sample volume on CF11
filtration, three replicates of 1.5-ml blood-parasite mix-
tures containing 10,000 parasites/μl were prepared and
filtered in parallel through CF11 columns loosely filled
to the 5-ml mark and packed to the 2.5-ml mark. To
investigate the effect of low parasite density on CF11 fil-
tration, three replicates of 3-ml blood-parasite mixtures
containing 5,000 parasites/μl were prepared and filtered
in parallel through CF11 columns packed to the 5.5-ml
mark. In both experiments, unfiltered blood-parasite
mixtures were prepared as control samples. The effect
of parasite density on CF11 and LP filtration was tested
in Pursat, Cambodia, using P. falciparum isolates
obtained from patients with malaria who had parasite
densities ranging from 20,000-475,000/μl.
Routine blood collection for further validation and
sequencing
To determine how CF11 filtration performed during a
routine blood collection protocol, 3 ml blood were
obtained from 51 patients presenting with falciparum
malaria in Ratanakiri, Cambodia. Blood samples were
passed through CF11 columns and the filtrates were
transported on ice to the laboratory in Phnom Penh,
where the samples were centrifuged to obtain RBC
pellets.
DNA quantification
DNA was extracted from leukocyte-depleted and unfil-
tered control samples using Qiamp DNA Blood Midi
Kits (Qiagen, Venlo, Netherlands) according to the man-
ufacturer’s protocol. Total DNA from experiments using
P. falciparum clones was estimated with a SpectraMax
M2 Microplate Reader (Molecular Devices, Sunnyvale,
Figure 1 Packed CF11 column ready for storage, shipping or
use (A) and filtration of blood-PBS mixture through CF11
column into collection tube (B).
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CA, USA) using the Quant-IT PicoGreen dsDNA Assay
Kit (Invitrogen, Carlsbad, CA, USA). The standard curve
ranged from 0.20 to 50 ng/μl. Total DNA from experi-
ments using P. falciparum isolates was estimated with a
Qubit 2.0 Fluorometer (Invitrogen, Carlsbad, CA, USA)
using both the dsDNA HS and BR Assay kits.
Quantitative real-time PCR (qPCR) was used to mea-
sure the relative amounts of human and parasite DNA in
each sample. Primers targeting the human LRAP (F: 5’-
ACGTTGGATGAATTTTCCACTGGATTCCAT-’3; R:
5’-ACGTTGGATGTGAACCATGCTCCTTGCATC-’3)
and TLR9 (F: 5’-ACGTTGGATGCAAAGGGCTGG
CTGTTGTAG-’3; R: 5’- ACGTTGGATGTCTACCAC-
GAGCACTCATTC-’3) genes and the P. falciparum
AMA-1 gene (F: 5’-ACGTTGGATGGATTCTCTTTC-
GATTTCTTTC-’3; R: 5’-ACGTTGGATGTGCTAC-
TACTGCTTTGTCCC-’3) were used to amplify DNA
from samples, negative controls and standards in dupli-
cate. Amplification occurred in an Applied Biosystems
7300 or StepOne real-time PCR machine. Human placen-
tal and P. falciparum (3D7 clone) genomic DNA stan-
dards ranged from 0.20 to 50 ng/μl. For each 25 μl
reaction, 12.5 μl SYBR Green qPCR Master Mix (Applied
Biosystems, Foster City, CA, USA) was mixed with 1.5 μl
of each forward and reverse primers at 2 μM concentra-
tions, 7.5-8.5 μl water, and 1-2 μl of template DNA. Reac-
tion conditions were previously reported [3]: an initial
denaturing step of 95°C for 10 minutes, five cycles of 94°
C for 45 seconds, 56°C for 45 seconds, 72°C for 45 sec-
onds, followed by 30 cycles of 94°C for 45 seconds, 65°C
for 45 seconds and 72°C for 45 seconds and one dissocia-
tion cycle (conditions vary by real-time PCR instrument).
Results were analysed using Applied Biosystems 7300
System SDS or StepOne v2.0 software.
qPCR quantification of AMA-1 and TLR9 or LRAP
was used to determine the proportions of P. falciparum
and human DNA in the sample. Total DNA was esti-
mated by multiplying the concentration given by Spec-
tramax or Qubit by the extracted sample volume.
Statistical comparisons
Means, variance, standard errors and statistical compari-
sons of means were calculated using Stata 11 software.
Boxplots indicating medians, interquartile ranges and
outliers were also generated using Stata 11.
Results
Comparison of unmodified LP and CF11 filtration for
leukocyte depletion
Filtration of blood-parasite mixtures using unmodified
LP and CF11 methods in parallel successfully depleted
human DNA to 1% and 6% of total DNA, respectively
(Figure 2A), well below the current Illumina sequencing
threshold of < 50%. CF11 was more effective than LP in
recovering total DNA from blood-parasite mixtures
(mean 1.11 μg vs. 0.37 μg; p = 0.03) (Figure 2B). All 15
CF11-filtered parasitized blood samples and 12 of 14
LP-filtered parasitized blood samples yielded < 50%
human DNA contamination (Figure 3A). Human DNA
contamination was lower for parasitized blood filtered
by CF11 than by LP (mean 2.4% vs. 15.9%; p = 0.03)
(Figure 3B). Recovery of total DNA was comparably
high in both sets of samples (mean 4.64 μg for CF11 vs.
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Figure 2 Percent human DNA (A) and total DNA (B) as
estimated by qPCR after leukocyte depletion of blood-parasite
mixtures. The volume and parasite density of blood-parasite
mixtures were 3 ml and 10,000/μl except where stated otherwise.
Three replicates for each filtration method were performed. Dashed
lines indicate current criteria for Illumina sequencing: < 50% human
DNA and > 500 ng total DNA. LP = Lymphoprep + Plasmodipur,
CF11 = filtration using a 5.5-ml CF11 column, CF11 O/N = CF11
filtrate held overnight prior to removal of supernatant, CF11 4 ml =
filtration using a 4-ml CF11 column, CF11 low vol = filtration of a
1.5-ml blood-parasite mixture containing 10,000 parasites/μl, CF11
low para = filtration of a 3-ml blood-parasite mixture containing
5,000 parasites/μl, NF = no filtration, NF low para = no filtration of a
3-ml blood-parasite mixture containing 5,000 parasites/μl. Box plots
show median and interquartile range.
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2.86 μg for LP; p = 0.46) One LP-filtered sample failed
to produce a human DNA estimate by qPCR and was
omitted from the analysis.
Procedural modifications of CF11 filtration method
To explore whether CF11 filtrates could be processed
without centrifugation, CF11-filtered blood-parasite mix-
tures were refrigerated overnight. The RBC pellet
formed during overnight settling was not as tightly
packed as that formed during centrifugation and
required careful handling when removing supernatant to
prevent disruption. This modification resulted in ade-
quate human DNA depletion (mean contamination 11%)
(Figure 2A) and total DNA recovery (mean 1.22 μg)
(Figure 2B). Columns with less CF11 powder, packed to
the 4-ml mark rather than to the 5.5-ml mark, also
yielded high total DNA (mean 1.56 μg) and a sufficiently
low proportion of human DNA (mean 30%) (Figure 2A
and 2B).
Blood volume and parasite density
All CF11-filtered blood-parasite mixtures (3 ml volume,
10,000/μl parasite density) consistently yielded samples
with < 30% human DNA contamination and > 500 ng
total DNA (Figure 2A and 2B). However, the ex vivo
study of P. falciparum isolates with interesting pheno-
types can be difficult if blood volumes are limited and
parasite densities are low. To determine whether such
limitations might significantly reduce the quality of DNA
samples, CF11 filtrations were repeated using blood-para-
site mixtures of lower volume (1.5 ml) or lower parasite
densities (5,000/μl). CF11 filtration of low-volume sam-
ples (1.5 ml; 10,000 parasites/μl) produced acceptable
human DNA contamination (mean 28%) and mean total
DNA (0.51 μg), but individual yields of total DNA were
highly variable, ranging from 0.15 to 1.09 μg (Figure 2A
and 2B). CF11 filtration of low parasite density samples
(3 ml; 5,000 parasites/μl) produced adequate amounts of
total DNA (mean 2.68 μg) but unacceptable human DNA
contamination (mean 77%) (Figure 2A and 2B). Thus,
reducing sample volumes or parasite densities by half
failed to reliably produce DNA samples acceptable for
Illumina sequencing.
Filtration of P. falciparum-infected blood obtained
from patients with malaria (Pursat, Cambodia) using the
CF11 and LP methods consistently achieved high-quality
results at parasite densities ranging from 20,000 to
475,000/μl (Figure 3A and 3B). At parasite densities <
50,000/μl and 50,000-100,000/μl, both filtration methods
depleted human DNA contamination to ≤ 30% and pro-
duced mean DNA yields > 1 μg. Samples with > 100,000
parasites/μl yielded several micrograms of DNA with <
5% human DNA contamination.
Validation of routine blood collection for illumina
sequencing
The 51 parasitized blood samples that were collected
and CF11-filtered in Ratanakiri, Cambodia, ranged in
parasite density from 15,000 to 290,000/μl and yielded a
mean 0.64 μg total DNA with 34% human DNA con-
tamination. All 51 samples met quality standards and
have been successfully sequenced on the Illumina plat-
form at the Wellcome Trust Sanger Institute (Hinxton,
UK).
Discussion
As next-generation sequencing technologies improve,
both costs and stringency of DNA sample quality
requirements continue to fall. Between 2009 and 2011,
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requirements for Illumina sequencing of P. falciparum
DNA by the Wellcome Trust Sanger Institute have
relaxed from 30% to 50% human DNA contamination.
Moreover, the possibility of sequencing multiple DNA
samples in a single lane of a flow cell (’multiplex
sequencing’) has decreased costs immensely while yield-
ing ~2 GB of P. falciparum genomic sequence data per
sample, with further improvements anticipated in com-
ing years. To take advantage of these increasingly acces-
sible tools, researchers need scalable procedures for
DNA sample preparation in minimally equipped field
sites.
This study shows that CF11 columns can be used to
effectively deplete human DNA from parasitized blood
and achieve Illumina sequencing requirements for total
DNA yield and percent human DNA contamination,
using sample volumes and parasite densities comparable
to those used in LP filtration experiments [3]. A major
advantage of CF11 over LP filtration is cost-effective-
ness. CF11 columns cost approximately one USD each,
compared to 10-50 USD for the Plasmodipur filter
alone. Additionally, CF11 filtration is a very simple one-
step procedure that does not require specialized equip-
ment. A centrifugation step is only used to pellet RBCs
after CF11 filtration and can be replaced with a conveni-
ent overnight period of refrigeration to allow the RBCs
to pellet by gravity. These advantages should enable a
large share of the malaria research community to pro-
duce parasite DNA samples appropriate for highly paral-
lel sequencing and microarray technologies.
Because CF11 columns are hand-made rather than
commercially produced, variation in the length of the
column is likely to occur. Samples filtered in columns
packed with less CF11 powder exhibited higher human
DNA contamination but still met the threshold level for
sequencing, indicating that some variation in column
preparation can be tolerated. Samples with low blood
volumes (1.5 ml) or parasite densities (5,000/μl) did not
consistently achieve sufficient human DNA depletion or
total DNA recovery when filtered with either the CF11
or LP method. Whole-genome amplification (WGA)
after DNA isolation [13] could boost the amount of
starting material in cases where human DNA removal is
satisfactory but total DNA yield is low. WGA may
therefore be useful in enabling genomic characterization
of CF11-filtered blood samples with low starting volume,
such as those collected from very young children and
patients with severe malarial anaemia. It may also be
useful in processing blood samples with low parasite
densities, as is often the case in patients with a recru-
descent parasitaemia after anti-malarial treatment and
those with high levels of naturally acquired immunity.
Although specific parameters have not been rigorously
tested, observations in the field have indicated that
CF11 and parasitized blood can be effectively stored and
used in a variety of environmental conditions. CF11
kept in an airtight container with regularly replaced
desiccant and stored in a cool place can be used for at
least three months, even in climates with high heat and
humidity (unpublished observation). EDTA-treated
blood stored at 4°C for up to 24 hours prior to CF11 fil-
tration was successfully processed for Illumina DNA
sequencing (unpublished observation), but for RNA ana-
lysis, no more than six hours of refrigeration is sug-
gested (ZB Bozdech, personal communication). Updates
to the range of storage conditions will be made to the
WWARN protocol [12] as more information becomes
available.
Conclusions
CF11 filtration currently offers the best cost-effective,
one-step approach to remove human DNA from P. falci-
parum-infected whole blood samples and can be suc-
cessfully implemented in large genome-wide sequencing
studies of P. falciparum isolates from patients with
malaria.
Abbreviations
RBC: Red Blood Cell; LP: Lymphoprep + Plasmodipur; PBS: Phosphate
Buffered Saline.
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